Loading...
XLON
CTEC
Market cap5.57bUSD
Jul 10, Last price  
214.20GBP
Name

ConvaTec Group PLC

Chart & Performance

D1W1MN
XLON:CTEC chart
P/E
31.35
P/S
2.25
EPS
0.09
Div Yield, %
2.37%
Shrs. gr., 5y
0.27%
Rev. gr., 5y
5.62%
Revenues
2.49b
+8.78%
1,700,700,0001,733,900,0001,650,400,0001,688,300,0001,764,600,0001,832,100,0001,827,200,0001,894,300,0002,038,300,0002,072,500,0002,142,400,0002,289,200,0002,490,170,962
Net income
179m
-6.21%
-173,700,000-286,500,000-93,400,000-202,800,000158,400,000221,600,0009,800,000112,500,000117,600,00062,900,000130,300,000190,500,000178,671,552
CFO
480m
+21.12%
229,100,000147,300,000100,300,00074,900,000306,600,000352,000,000401,800,000399,500,000305,900,000281,700,000367,400,000396,200,000479,860,742
Dividend
Aug 21, 20251.399 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ConvaTec Group Plc is a global medical technology company focused on creating, producing, and distributing a wide array of healthcare products. Their offerings span several key areas: Advanced Wound Management: This includes specialized dressings and skincare solutions for treating both acute and chronic wounds, which can arise from conditions like diabetes, prolonged immobility, venous disease, traumatic injuries, burns, or surgical interventions. Ostomy Care: The company provides vital devices, accessories, and support services for individuals who have undergone ostomy procedures, often necessitated by conditions such as colorectal or bladder cancer, inflammatory bowel disease, or obesity. Continence and Critical Care: This division offers intermittent urinary catheters and related products to help manage urinary continence issues for patients with spinal cord injuries, multiple sclerosis, spina bifida, and other urological conditions. It also supplies a range of devices crucial for intensive care units and broader hospital settings. Specialized Monitoring and Management Systems: ConvaTec develops advanced systems for managing acute fecal incontinence, meticulously monitoring urine output, and assessing intra-abdominal pressure. Disposable Medical Supplies: Their portfolio includes a variety of single-use medical items such as wound drainage systems, urine collection bags and catheters, equipment for airway management and oxygen therapy, suction apparatus, gastroenterology tubes, and securement devices. Infusion Technology: They also manufacture disposable infusion sets for insulin pumps used in diabetes care, as well as for other continuous infusion treatments. ConvaTec distributes its products globally to a diverse clientele, including pharmacies, hospitals, and various acute and post-acute healthcare providers, either directly or via a network of distributors and wholesalers. Their customer base encompasses healthcare professionals, patients, and other manufacturers. Founded in 1978, ConvaTec Group Plc is headquartered in Reading, United Kingdom.
IPO date
Oct 26, 2016
Employees
10,000
Domiciled in
GB
Incorporated in
GB

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT